INTS vs L
Intensity Therapeutics, Inc. Common stock (INTS) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
INTS does not have a complete income-statement cache yet.
Latest reported L revenue for 2024-12-31 was $17.51B. Net income was $1.49B. Revenue was up 10.1% from 2023-12-31 to 2024-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
INTS currently screens at market cap $7.7M. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the INTS and L stock pages for the full models.
Not investment advice.